Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Chronic Myelomonocytic Leukemia

NCT00005846: Tipifarnib in Treating Patients With Myeloproliferative Disorders

Active, not recruiting

1/2

tipifarnib

Stanford University, National Cancer Institute (NCI)

Leukemia, Myelodysplastic/Myeloproliferative Neoplasms

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites